Access to Medicines - Our Approach | Takeda Pharmaceuticals

Tree with sun shining through

Access to Medicines

Globally, more than 2 billion people lack access to essential medicines, most of whom live in low- and middle-income countries (LMICs) and countries with evolving healthcare systems.

We are focused on improving people’s lives by researching, developing and bringing to market innovative medicines and vaccines that everyone can access – regardless of where they live or their ability to pay.

We do this not only by ensuring our medicines and vaccines are available and affordable, but also by working in partnership to build capabilities within the health care systems that deliver them.

Broadening sustainable, equitable access to medicines and vaccines is not only embedded in our values, it’s integrated in to our purpose-led sustainability strategy for business growth.

Broadening sustainable, equitable access

Our programs are aimed at broadening sustainable and equitable access to medicines. To do this, we pursue an “end-to-end” approach that unlocks barriers to access across the patient pathway.

The three pillars of our approach

Accelerating sustainable, equitable access

Progress Highlights 2023

Our 2023 Access to Medicines Update highlights ongoing programs aimed at unlocking barriers to access in health care systems, bridging affordability barriers, and creating societal value through.
See the highlightsArrow bottom

“We’re committed to discovering and delivering life-transforming medicines and vaccines to patients regardless of where they live or what they can afford to pay.”

Christophe WeberPresident & CEO